Clearmind Medicine Inc. has signed a non-binding term sheet with Dr. Glitter Pty Ltd to collaborate on the development and commercialization of a MEAI-based alcohol substitute using Dr. Glitter's ...

descSPIM enables three-dimensional imaging of diverse tissues like neural cells and cancerous tumors. The widespread dissemination and adoption of descSPIM can accelerate biomedical discoveries. Three ...

We maintain our CAD 39 fair value estimate for Boralex BLX following the company’s first-quarter results. We view the shares as fairly valued. There were few surprises in Boralex’s first quarter. The ...

Initial implementation of an electronic oncology trigger tool for adverse event detection. This is an ASCO Meeting Abstract from the 2020 ASCO Quality Care Symposium. This abstract does not include a ...

XCF’s modular, scalable renewable fuel platform across Australia, targeting development of three renewable fuel production facilities XCF to receive a 12.5%equity stake, licensing fees, and one board ...

Reimbursable Advisory Services on Support for Establishing the System for Strategic Planning and Development Management and for Preparing the 2030 National Development Strategy We welcome the ...

From testing drugs to developing vaccines, the close study of the immune system is key to improving real-world health outcomes. T-cells are integral to this research, as these white blood cells help ...

The strategy of providing incentives to companies involves potential downsides that rarely are fully appreciated. In today’s headline-focused media culture, short-term political optics often outweigh ...

DeFi Development Corp. (Nasdaq: DFDV) has announced that it now holds a total of 999,999 Solana (SOL) and SOL equivalents on its balance sheet, marking a significant increase following a recent ...